Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 2
1967 2
1970 2
1971 2
1973 3
1976 1
1978 1
1979 2
1980 2
1981 3
1982 3
1983 4
1984 3
1985 5
1986 2
1987 1
1988 1
1989 2
1990 2
1991 6
1992 3
1993 4
1994 6
1995 7
1996 5
1997 3
1998 3
1999 11
2000 6
2001 11
2002 4
2003 4
2004 9
2005 7
2006 8
2007 8
2008 7
2009 11
2010 7
2011 11
2012 12
2013 8
2014 12
2015 15
2016 11
2017 12
2018 17
2019 17
2020 9
2021 15
2022 11
2023 16
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

318 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous mastocytosis: A dermatological perspective.
Di Raimondo C, Del Duca E, Silvaggio D, Di Prete M, Lombardo P, Mazzeo M, Spallone G, Campione E, Botti E, Bianchi L. Di Raimondo C, et al. Australas J Dermatol. 2021 Feb;62(1):e1-e7. doi: 10.1111/ajd.13443. Epub 2020 Oct 11. Australas J Dermatol. 2021. PMID: 33040350 Review.
Cutaneous mastocytosis is classified into (i) maculopapular cutaneous mastocytosis, also known as urticaria pigmentosa; (ii) diffuse cutaneous mastocytosis; and (iii) mastocytoma of the skin. ...Diagnosis of cutaneous mastocytos …
Cutaneous mastocytosis is classified into (i) maculopapular cutaneous mastocytosis, also known as urticaria pigm …
Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
Castells M, Butterfield J. Castells M, et al. J Allergy Clin Immunol Pract. 2019 Apr;7(4):1097-1106. doi: 10.1016/j.jaip.2019.02.002. J Allergy Clin Immunol Pract. 2019. PMID: 30961835 Review.
Patients with clonal mast cell activation syndromes (MCAS) including cutaneous and systemic mastocytosis (SM) may present with symptoms of mast cell activation, but in addition can have organ damage from the local effects of tissue infiltration by clonal mast cells. …
Patients with clonal mast cell activation syndromes (MCAS) including cutaneous and systemic mastocytosis (SM) may present with …
The international consensus classification of mastocytosis and related entities.
Leguit RJ, Wang SA, George TI, Tzankov A, Orazi A. Leguit RJ, et al. Virchows Arch. 2023 Jan;482(1):99-112. doi: 10.1007/s00428-022-03423-3. Epub 2022 Oct 10. Virchows Arch. 2023. PMID: 36214901 Review.
The disease can be limited to the skin (cutaneous mastocytosis) that is mostly seen in childhood and usually behaves in a benign fashion. Adult patients most often present with systemic disease with or without skin lesions. This includes indolent forms such as indol …
The disease can be limited to the skin (cutaneous mastocytosis) that is mostly seen in childhood and usually behaves in a beni …
Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management.
Pardanani A. Pardanani A. Am J Hematol. 2021 Apr 1;96(4):508-525. doi: 10.1002/ajh.26118. Epub 2021 Feb 21. Am J Hematol. 2021. PMID: 33524167 Free article. Review.
OVERVIEW: Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast cells (MC) in extra-cutaneous organs. ...
OVERVIEW: Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast cells (MC) in extra-cutaneous organs …
New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and Therapy.
Valent P, Akin C, Sperr WR, Horny HP, Arock M, Metcalfe DD, Galli SJ. Valent P, et al. Annu Rev Pathol. 2023 Jan 24;18:361-386. doi: 10.1146/annurev-pathmechdis-031521-042618. Epub 2022 Oct 21. Annu Rev Pathol. 2023. PMID: 36270293 Free article. Review.
Mastocytosis is a heterogeneous group of neoplasms defined by a numerical increase and accumulation of clonal mast cells (MCs) in various organ systems. The disease may present as cutaneous mastocytosis or systemic mastocytosis (SM). On the basis of hi …
Mastocytosis is a heterogeneous group of neoplasms defined by a numerical increase and accumulation of clonal mast cells (MCs) in var …
Mastocytosis and Mast Cell Activation Disorders: Clearing the Air.
Jackson CW, Pratt CM, Rupprecht CP, Pattanaik D, Krishnaswamy G. Jackson CW, et al. Int J Mol Sci. 2021 Oct 19;22(20):11270. doi: 10.3390/ijms222011270. Int J Mol Sci. 2021. PMID: 34681933 Free PMC article. Review.
Some mast cell disorders are associated with specific genetic mutations (such as the D816V gain-of-function mutation) with resultant clonal disease. Such disorders include cutaneous mastocytosis, systemic mastocytosis (SM), its variants (indolent/ISM, smolder …
Some mast cell disorders are associated with specific genetic mutations (such as the D816V gain-of-function mutation) with resultant clonal …
Urticarial vasculitis: Clinical and laboratory findings with a particular emphasis on differential diagnosis.
Marzano AV, Maronese CA, Genovese G, Ferrucci S, Moltrasio C, Asero R, Cugno M. Marzano AV, et al. J Allergy Clin Immunol. 2022 Apr;149(4):1137-1149. doi: 10.1016/j.jaci.2022.02.007. J Allergy Clin Immunol. 2022. PMID: 35396080 Review.
Urticarial vasculitis (UV) is a rare cutaneous vasculitis of small vessels characterized by recurrent episodes of wheal-like lesions that tend to last more than 24 hours, healing with a residual ecchymotic postinflammatory hyperpigmentation. ...A focus on its main differen …
Urticarial vasculitis (UV) is a rare cutaneous vasculitis of small vessels characterized by recurrent episodes of wheal-like lesions …
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.
Hartmann K, Escribano L, Grattan C, Brockow K, Carter MC, Alvarez-Twose I, Matito A, Broesby-Olsen S, Siebenhaar F, Lange M, Niedoszytko M, Castells M, Oude Elberink JNG, Bonadonna P, Zanotti R, Hornick JL, Torrelo A, Grabbe J, Rabenhorst A, Nedoszytko B, Butterfield JH, Gotlib J, Reiter A, Radia D, Hermine O, Sotlar K, George TI, Kristensen TK, Kluin-Nelemans HC, Yavuz S, Hägglund H, Sperr WR, Schwartz LB, Triggiani M, Maurer M, Nilsson G, Horny HP, Arock M, Orfao A, Metcalfe DD, Akin C, Valent P. Hartmann K, et al. J Allergy Clin Immunol. 2016 Jan;137(1):35-45. doi: 10.1016/j.jaci.2015.08.034. Epub 2015 Oct 21. J Allergy Clin Immunol. 2016. PMID: 26476479 Review.
Cutaneous lesions in patients with mastocytosis are highly heterogeneous and encompass localized and disseminated forms. Although a classification and criteria for cutaneous mastocytosis (CM) have been proposed, there remains a need to better define su …
Cutaneous lesions in patients with mastocytosis are highly heterogeneous and encompass localized and disseminated forms. Altho …
Pediatric mastocytosis.
Hussain SH. Hussain SH. Curr Opin Pediatr. 2020 Aug;32(4):531-538. doi: 10.1097/MOP.0000000000000922. Curr Opin Pediatr. 2020. PMID: 32692050 Review.
KIT mutations are found in the majority of pediatric cutaneous mastocytosis but are not correlated with prognosis. Serum tryptase levels may be elevated in pediatric cutaneous mastocytosis patients without systemic mastocytosis. ...The low risk …
KIT mutations are found in the majority of pediatric cutaneous mastocytosis but are not correlated with prognosis. Serum trypt …
Advanced systemic mastocytosis-Revised classification, new drugs and how we treat.
Pardanani A, Reichard K, Tefferi A. Pardanani A, et al. Br J Haematol. 2024 Feb;204(2):402-414. doi: 10.1111/bjh.19245. Epub 2023 Dec 6. Br J Haematol. 2024. PMID: 38054381 Review.
Mastocytosis constitutes the neoplastic proliferation of mast cells and is broadly classified into systemic mastocytosis (SM), cutaneous mastocytosis and mast cell sarcoma. ...
Mastocytosis constitutes the neoplastic proliferation of mast cells and is broadly classified into systemic mastocytosis (SM), …
318 results